Literature DB >> 18475206

Impact on quality of life after mastoid obliteration.

John L Dornhoffer1, Jason Smith, Gresham Richter, Jacob Boeckmann.   

Abstract

OBJECTIVES/HYPOTHESIS: To understand the long-term impact on quality of life (QOL) in patients undergoing mastoid obliteration surgery for a chronically draining cavity, using the Glascow Benefit Inventory (GBI) QOL survey, and to correlate these findings to perceived changes in drainage and hearing. STUDY
DESIGN: Retrospective chart review.
METHODS: Adult patients undergoing mastoid obliteration and restoration of the middle ear space with cartilage reconstruction of the tympanic membrane, with at least 3-year follow-up, were contacted by phone to solicit participation. Those who agreed to participate were mailed the GBI and consent documents with a prepaid self-addressed envelope.
RESULTS: Of 80 patients meeting the inclusion criteria, 37 were successfully contacted and agreed to participate, yielding 23 returned questionnaires. The vast majority (19 of 23; 83%) reported improved QOL after surgery, with the most positive effects seen on confidence and social situations, and patients experiencing less inconvenience, self-consciousness, and embarrassment. Eighty-three percent reported a perceived improvement in hearing; 74% reported an improvement in drainage. Over 90% would recommend the procedure to a family member. The average score on the GBI was 28.9, and a two-tailed one-sample t test showed that mastoid obliteration significantly improved QOL in our patients (t = 4.65, P < .001). There was a fairly good correlation between the perceived improvement in QOL with improvement in hearing and/or drainage.
CONCLUSIONS: The GBI is a valuable tool for evaluating patient satisfaction after revision surgery for a draining cavity. This information is helpful in understanding the impact of a draining cavity on an individual's life and may be beneficial in preoperative selection and counseling.

Entities:  

Mesh:

Year:  2008        PMID: 18475206     DOI: 10.1097/MLG.0b013e318173dd7e

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  13 in total

1.  Health Related Quality of Life after the Bony Obliteration Tympanoplasty for COM with Cholesteatoma using the COMQ12 - A Disease Specific PROM.

Authors:  Wouter Baetens; Joost van Dinther; Robby Vanspauwen; Youri Maryn; Andrzej Zarowski; Erwin Offeciers
Journal:  J Int Adv Otol       Date:  2019-12       Impact factor: 1.017

Review 2.  [State of the art of quality-of-life measurement in patients with chronic otitis media and conductive hearing loss].

Authors:  S Lailach; I Baumann; T Zahnert; M Neudert
Journal:  HNO       Date:  2018-08       Impact factor: 1.284

3.  Mental health and quality of life in patients with chronic otitis media.

Authors:  Salih Bakir; Vefa Kinis; Yasin Bez; Ramazan Gun; Ediz Yorgancilar; Musa Ozbay; Bülent Aguloglu; Faruk Meric
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05-08       Impact factor: 2.503

Review 4.  A review of current progress in acquired cholesteatoma management.

Authors:  Chin-Lung Kuo; Wen-Huei Liao; An-Suey Shiao
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-17       Impact factor: 2.503

5.  Implantation of the Bonebridge BCI 602 after Mastoid Obliteration with S53P4 Bioactive Glass: A Safe Method of Treating Difficult Anatomical Conditions-Preliminary Results.

Authors:  Bartłomiej Król; Katarzyna Beata Cywka; Magdalena Beata Skarżyńska; Piotr Henryk Skarżyński
Journal:  Life (Basel)       Date:  2021-04-22

6.  Mastoidectomy and mastoid obliteration with autologous bone graft: a quality of life study.

Authors:  George Kurien; Kate Greeff; Nahla Gomaa; Allan Ho
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-09-23

7.  Uniform Registration Agreements on Cholesteatoma Care: A Nationwide Consensus Procedure.

Authors:  Fleur A Ten Tije; Robert J Pauw; Jozé C Braspenning; Raphael J B Hemler; Annette J Ter Schiphorst; Erik F Hensen; Lisa van der Putten; Sophia E Kramer; Paul Merkus
Journal:  Otol Neurotol       Date:  2020-09       Impact factor: 2.619

8.  Mastoid cavity obliteration leads to a clinically significant improvement in health-related quality of life.

Authors:  Nora M Weiss; David Bächinger; Jannik Botzen; Wilma Großmann; Robert Mlynski
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-03-06       Impact factor: 2.503

9.  Autologous Platelet- and Extracellular Vesicle-Rich Plasma Is an Effective Treatment Modality for Chronic Postoperative Temporal Bone Cavity Inflammation: Randomized Controlled Clinical Trial.

Authors:  Domen Vozel; Darja Božič; Marko Jeran; Zala Jan; Manca Pajnič; Ljubiša Pađen; Nejc Steiner; Veronika Kralj-Iglič; Saba Battelino
Journal:  Front Bioeng Biotechnol       Date:  2021-07-07

Review 10.  Mastoid obliteration and reconstruction techniques: A review of the literature.

Authors:  Michelle Lupa Mendlovic; Daniella Alejandra Monroy Llaguno; Ivan Hermann Schobert Capetillo; Juan Carlos Cisneros Lesser
Journal:  J Otol       Date:  2021-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.